Aripiprazole Tablet
Product Images NDC 72162-2369

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 72162-2369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aripiprazole-fig-16.jpg (Aripiprazole Fig 16)

FDA Label Image

Aripiprazole-fig-17 (Aripiprazole Fig 17)

The provided text includes information on the counts of subjects at risk for the Aripiprazole and Placebo groups, as well as the proportions with relapse at different time points in a study. The data shows the number of subjects at risk over time, with time points indicated in days from randomization. The clarity of the specific results may need further context to interpret accurately.*

FDA Label Image

Effects Of Other Drugs On Dehydro-aripiprazole (Aripiprazole Fig10)

FDA Label Image

Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig11)

FDA Label Image

Effects Of Intrinsic Factors On Aripiprazole (Aripiprazole Fig12)

This text appears to be a statistical analysis related to Aripiprazole fold change and confidence intervals. It mentions a 30% confidence interval and the fold change relative to a reference value. The document might be discussing the impact of Aripiprazole on certain parameters or data sets.*

FDA Label Image

Effects Of Intrinsic Factors On Dehydro-aripiprazole (Aripiprazole Fig13)

This text appears to be related to "PR Dshyero-Arlrazse Fod Change and sk CI" and potentially mentions something about "Renal impairment" and a "Change in reference." Additional context or clarification would be needed to provide a more accurate description.*

FDA Label Image

Effects Of Other Drugs On Aripiprazole (Aripiprazole Fig9)

FDA Label Image

Aripiprazole-fig-18 (Aripiprazole Fig 18)

This text discusses the least-squares mean change in YGTSS Total TIC Score over a specified period of treatment. It includes information on changes in the YGTSS Total TIC Score from baseline and mentions the number of weeks of treatment. The document appears to be part of a study or report evaluating these changes in the YGTSS Total TIC Score.*

FDA Label Image

Aripiprazole Structure (Aripiprazole Fig8)

FDA Label Image

Aripiprazole-graph (Aripiprazole Graph)

FDA Label Image

Label (Lbl721622369)

This text contains information about Aripiprazole Tablets, USP, with each tablet containing 10 mg of Aripiprazole. It provides storage instructions, NDC number, and manufacturing details. It also mentions the need to keep the tablets and all medicines out of the reach of children and to dispense the Medication Guide to each patient. Further dosage and indication information can be found at the provided website.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.